
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
An international research team has demonstrated that treating HIV with interleukin-2 is ineffective, and as a result, they have recommended in an article published in The New England Journal of Medicine that clinical trials on this compound be stopped. IL-2 is sometimes used as a complement to highly active antiretroviral therapy. Since HAART controls replication of viruses in the blood, doctors thought IL-2 would help regenerate more CD4 immune cells, which serve as an indicator of viral progression. It was thought that IL-2 increased the natural immunity of patients by helping immune cells mature and multiply. "Our results show that IL-2 has no effect on the development of AIDS or on patient survival," says Jean-Pierre Routy of McGill University. "More precisely, while the presence of IL-2 leads to a faster increase of CD4 cells, these cells are less functional than the CD4 cells that regenerate naturally in patients who do not receive IL-2. This means IL-2 treatment provides no benefit and does not prevent AIDS-related infectious diseases."
From our Sponsors
Most Popular
Plus: Featured Video